| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8281ac9f4fb11f15a5da018344453338 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
| filingDate |
2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_519edf3610a51061869efe2d0478612a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e8a3f3873f5921eb9f57df16e0757df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7836e6542d40b12849b2df8ca212382b |
| publicationDate |
2003-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03043642-A1 |
| titleOfInvention |
Novel tylosin derivatives having antibacterial activity |
| abstract |
There are described novel substituted tylosin analogs and pharmaceutically acceptable compositions comprinsing a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier. Also described is a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeuticall-effective amount of a compound of the invention, and processes for the preparation of such compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8518900-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016519153-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8461121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8263753-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8227429-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104045675-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103275154-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9593140-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9771389-B2 |
| priorityDate |
2001-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |